Delivery Order SPE2DB22D3016-SPE2DB24FAYQ2
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $8,159.16 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,200 units of the pharmaceutical product PHESGO (600 mg/30,000 unit 15 ml). This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,564,376,730 units of the pharmaceutical product PHESGO (1,200-600MG-30,000 unit, 15ML) at a ceiling value of $8,159.16. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued...
- The Defense Logistics Agency (DLA) awarded a $10,641.84 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp for the supply of 4,565,666,681 units of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceutical products. This contract has a completion date of September 24, 2024 and does not utilize any set-aside designations. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various agencies to provide a range of medical commodities,...
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of the product "PHESGO 600-600 MG-20,000 UNIT 10ML." This is a firm fixed-price delivery order contract with an ultimate completion date of March 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,916.78, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML medical products. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 7, 2025. The contract is not designated as a set-aside and is considered an open competition award. AmerisourceBergen...
- This federal contract award, valued at $11,009.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product, with a completion date of December 27, 2024. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,232.07 firm-fixed-price contract is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML, a medical product. The contract has an ultimate completion date of June 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated for this award. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,458.39, is for the delivery of PHESGO 600-600 MG-20,000 UNIT 10ML pharmaceuticals. It is a firm fixed-price, non-set-aside contract with a performance period ending on May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, on July 17, 2025. The contract has a ceiling value of $5,458.39 and a completion date of August 7, 2025. The contract is for the supply of PHESGO 600-600 MG-20,000 UNIT 10ML, a pharmaceutical product. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a substantial Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,683.68, is for the delivery of PHESGO, a pharmaceutical product, in the amount of 1,200-600MG-30,000 units of 15ML. The contract is a firm fixed-price delivery order, with a completion date of July 28, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAYQ2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $10,641.84 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of 20,000 units of the drug PHESGO 600-600 MG in 10 ML vials, with a completion date of July 10, 2024. This order is placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.6k | 6/17/24 |